Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2010 / Cilt: 36 - Sayı: 2

Streptozotosin ile diyabet oluşturulan sıçanlarda pirolidyum dithiyokarbamat’ın böbrek dokusu üzerine koruyucu etkisi

Protective effect of pyrrolidine dithiocarbamate on kidney tissue in streptozotocin-induced diabetic rats

Pages
167–175
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: PDTC has a protective effect on renal injury secondary to diabetes and can be a treatment option for patients with diabetic nephropathy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we investigated protective effects of pyrrolidine dithiocarbamate (PDTC), which is an antioxidant and nuclear factor kappa B (NF-κB) inhibitor, on nephropathy in diabetic rat model.
📊
Key Findings & Data:Materials and methods: Twenty-eight Sprague-Dawley rats were allocated into 3 groups.
💡
Conclusion & Impact:Conclusion: PDTC has a protective effect on renal injury secondary to diabetes and can be a treatment option for patients with diabetic nephropathy.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we investigated protective effects of pyrrolidine dithiocarbamate (PDTC), which is an antioxidant and nuclear factor kappa B (NF-&#954;B) inhibitor, on nephropathy in diabetic rat model. Materials and methods: Twenty-eight Sprague-Dawley rats were allocated into 3 groups. Control group (n=8) received no treatment; diabetes group (n=10) received single intraperitoneal (i.p.) injection of streptozotocin (STZ, 65 mg/kg) to induce experimental diabetes; and PDTC group (n=10) received i.p. 100 µL/day PDTC for a total of 10 weeks following diabetes induction with i.p. STZ injection. At the end of the study kidneys were excised from sacrificed rats, and glomerular and tubular changes were examined under light microscopy. Immunohistochemically, NF-&#954;B (p65) and inducible nitric oxide synthase (iNOS) expression were evaluated in the renal cortex. Results: In diabetes group, immunohistochemical NF-&#954;B expression was higher than control and PDTC groups (p<0.05). In PDTC group, NF-&#954;B expression level was very similar to control group, but less than diabetes group (p<0.05). Immunohistochemical iNOS expression was less in control group. In PDTC group, iNOS expression was more intense than control group (p<0.05), but less than that in diabetes group (p<0.05). Conclusion: PDTC has a protective effect on renal injury secondary to diabetes and can be a treatment option for patients with diabetic nephropathy.

Özet

Amaç: Bu çalışmada, nükleer faktör-kappa B (NF-κB) inhibitörü ve antioksidan özelliği olan pirolidyum dithiyokarbamat’ın (PDTC) diyabetik sıçan modelinde nefropati üzerine koruyucu etkisini araştırdık. Gereç ve yöntem: Sprague-Dawley cinsi 28 sıçan üç gruba ayrıldı. Kontrol grubu (n=8) tedavi almadı; diyabet grubuna (n=10) intraperitoneal (i.p.) streptozotosin (STZ, 65 mg/kg) verildi; ve PDTC grubuna (n=10) i.p. STZ ile diyabet oluşturulduktan sonra 10 hafta süreyle i.p. 100 µL/gün PDTC verildi. Çalışma sonunda öldürülen tüm sıçanların böbrekleri alındı. Işık mikroskobu altında glomeruler ve tübüler değişiklikler incelendi. İmmunohistokimyasal olarak renal kortekste NF-kappa B (p65), indüklenebilir nitrik oksit sentaz (iNOS) ekspresyonu değerlendirildi. Bulgular: Diyabet grubunda immunohistokimyasal NF-κB ekspresyonu kontrol ve PDTC grubuna göre artmış olarak izlendi (p<0.05). PDTC grubunda bu ekspresyon düzeyi kontrol grubuna yakın idi, diyabet grubuna göre ise daha düşüktü (p<0.05). İmmunohistokimyasal iNOS ekspresyonu kontrol grubunda daha azdı. PDTC grubunda ise kontrol grubuna göre boyanma daha yoğun (p<0.05) ve diyabet grubuna göre azalmış olarak izlendi (p<0.05). Sonuç: Diyabete bağlı gelişen renal hasara karşı PDTC’nin koruyucu etkisi vardır ve diyabetik nefropatili hastalarda bir tedavi seçeneği olabilir.

🔖

Cite This Article

ARAS, B., TUĞCU, V., EREN, G., MUTLU, B., UHRİ, M., ÖZBEK, E., TAŞÇI, A. İ. (2010). Streptozotosin ile diyabet oluşturulan sıçanlarda pirolidyum dithiyokarbamat’ın böbrek dokusu üzerine koruyucu etkisi. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 36 - Sayı: 2, 167–175. https://ajindex.com/articles/328114

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Montilla P, Barcos M, Munoz MC, Bujalance I, Munoz-Castaneda JR, Tunez I. Red wine prevents brain oxidative stress and nephropathy in streptozotocin-induced diabetic rats. J Biochem Mol Biol 2005
  2. PMID: 16202232 2. Noh H, Ha H, Yu MR, Kang SW, Choi KH, Han DS, et al. High glucose increases inducible NO production in cultured rat mesangial cells. Possible role in fibronectin production. Nephron 2002
  3. PMID: 11744809 3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993
  4. PMID: 11744809 4. Krolewski AS, Canessa M, Warram JH, Laffel LM, Christlieb AR, Knowler WC, et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988
  5. PMID: 3336401 5. Hyslop PA, Hinshaw DB, Halsey WA Jr, Schraufstätter IU, Sauerheber RD, Spragg RG, et al. Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem 1988
  6. PMID: 3338986 6. Oberley LW. Free radicals and diabetes. Free Radic Biol Med Review 1988
  7. PMID: 3075947 7. Yamamoto Y, Gaynor RB. Role of the NF-kappaB pathway in the pathogenesis of human disease states. Curr Mol Med 2001
  8. PMID: 11899077 8. Rangan G, Wang Y, Harris D. NF-kappaB signalling in chronic kidney disease. Front Biosci 2009
  9. PMID: 19273289 9. Panzer U, Steinmetz OM, Turner JE, Meyer-Schwesinger C, von Ruffer C, Meyer TN, et al. Resolution of renal inflammation: a new role for NF-kappaB1 (p50) in inflammatory kidney diseases. Am J Physiol Renal Physiol 2009
  10. F429-39. PMID: 19458123 10. Gilad E, Wong HR, Zingarelli B, Virág L, O’Connor M, Salzman AL, et al. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: Role of inhibition of NF-κB activation. FASEB J 1998
  11. PMID: 9619447 11. Chatterjee PK, Patel NS, Kvale EO, Cuzzocrea S, Brown PA, Stewart KN, et al. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 2002
  12. PMID: 11849439 12. Goligorsky MS, Brodsky SV, Noiri E. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 2002
  13. PMID: 11849438 13. Fischer PA, Dominguez GN, Cuniber